Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2013 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Other Working Capital Changes of -$8.1 million for Q2 2026, up 61.11% year-over-year from -$5.0 million in Q2 2025, and up 61.2% quarter-over-quarter from -$20.8 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$8.1 million for Q2 2026.
- In Q2 2026, Other Working Capital Changes rose 61.11% year-over-year to -$8.1 million; the TTM figure through Jun 2026 stood at -$64.1 million (up 21.56% YoY), while the FY2025 annual figure was -$69.7 million, up 55.53% from the prior year.
- Other Working Capital Changes for Q2 2026 stood at -$8.1 million, up from -$20.8 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $101.0 million in Q3 2025, with the low at -$90.3 million in Q4 2025.
- The 5-year median for Other Working Capital Changes is $8.8 million (2025), against an average of $8.8 million.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes soared 817.28% in 2023, then sank 327.94% in 2024.
- Ionis Pharmaceuticals' Other Working Capital Changes stood at -$15.8 million in 2022, then sank by 290.49% to -$61.8 million in 2023, then soared by 76.85% to -$14.3 million in 2024, then plunged by 33.77% to -$19.1 million in 2025, then jumped by 57.78% to -$8.1 million in 2026.
- Business Quant data shows IONS's Other Working Capital Changes at -$8.1 million in Q2 2026, -$20.8 million in Q1 2026, and -$19.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.88 Mn |
| Jun 30, 2026 | 30.88 Mn |
| Jun 30, 2026 | 30.88 Mn |
| Mar 31, 2026 | 7.39 Mn |
| Mar 31, 2026 | 7.39 Mn |
| Mar 31, 2026 | 7.39 Mn |
| Dec 31, 2025 | -90.28 Mn |
| Dec 31, 2025 | -90.28 Mn |
| Dec 31, 2025 | -90.28 Mn |
| Sep 30, 2025 | 100.95 Mn |
| Sep 30, 2025 | 100.95 Mn |
| Sep 30, 2025 | 100.95 Mn |
| Jun 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 10.17 Mn |
| Mar 31, 2025 | 12.37 Mn |
| Mar 31, 2025 | 12.37 Mn |
| Mar 31, 2025 | 12.37 Mn |
| Dec 31, 2024 | 17.70 Mn |
| Dec 31, 2024 | 17.70 Mn |